Generic name: carteolol hydrochloride
Dosage form: ophthalmic solution
Medically reviewed on September 19, 2017.
The usual dose is one drop of Ocupress Ophthalmic Solution, 1%, in the affected eye(s) twice a day.
If the patient’s IOP is not at a satisfactory level on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine or dipivefrin, and/or systemically administered carbonic anhydrase inhibitors, such as acetazolamide, can be instituted.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Ocupress (carteolol ophthalmic)
- Ocupress Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: ophthalmic glaucoma agents